These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36943583)

  • 1. Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates.
    Matcha S; Dillibatcha J; Raju AP; Chaudhari BB; Moorkoth S; Lewis LE; Mallayasamy S
    Paediatr Drugs; 2023 May; 25(3):365-375. PubMed ID: 36943583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic model.
    Thirion DJG; Pasche V; Matouk E; Marsot A
    Pediatr Pulmonol; 2020 May; 55(5):1154-1160. PubMed ID: 32119197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies.
    Illamola SM; Colom H; van Hasselt JG
    Br J Clin Pharmacol; 2016 Sep; 82(3):793-805. PubMed ID: 27198625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacometric approach to assist dosage regimen design in neonates undergoing therapeutic hypothermia.
    Matcha S; Raj EA; Mahadevan R; Raju AP; Rajesh V; Lewis LE; Mallayasamy S
    Pediatr Res; 2022 Jul; 92(1):249-254. PubMed ID: 34493833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Evaluation of Population Pharmacokinetic Models of Piperacillin in Preterm and Term Patients from Neonatal Intensive Care.
    Boer-Pérez FS; Lima-Rogel V; Mejía-Elizondo AR; Medellín-Garibay SE; Rodríguez-Báez AS; Rodríguez-Pinal CJ; Milán-Segovia RDC; Romano-Moreno S
    Eur J Drug Metab Pharmacokinet; 2024 Jul; ():. PubMed ID: 38951408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children.
    Tréluyer JM; Merlé Y; Tonnelier S; Rey E; Pons G
    Antimicrob Agents Chemother; 2002 May; 46(5):1381-7. PubMed ID: 11959572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
    Lugo G; Castañeda-Hernández G
    Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.
    Marsot A; Guilhaumou R; Riff C; Blin O
    Clin Pharmacokinet; 2017 Feb; 56(2):127-138. PubMed ID: 27324191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
    De Cock RF; Allegaert K; Schreuder MF; Sherwin CM; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2012 Feb; 51(2):105-17. PubMed ID: 22229883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.
    Zhao W; Biran V; Jacqz-Aigrain E
    Clin Pharmacokinet; 2013 Dec; 52(12):1127-34. PubMed ID: 24027065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
    Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM
    Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Validation of a Vancomycin Population Pharmacokinetic Model and Developing a New Dosage Regimen in Neonates.
    Lim CP; Tseng SH; Neoh CCC; Chen Q; Poon WB
    Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):687-697. PubMed ID: 35804218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of amikacin in a Korean clinical population.
    Jang SB; Lee YJ; Park MS; Song YG; Kim JH; Kim HK; Ahn BS; Park K
    Int J Clin Pharmacol Ther; 2011 Jun; 49(6):371-81. PubMed ID: 21612744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a new dosage regimen of amikacin based on pharmacokinetic parameters of Korean neonates.
    An SH; Kim JY; Gwak HS
    Am J Health Syst Pharm; 2014 Jan; 71(2):122-7. PubMed ID: 24375604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of amikacin in neonates.
    Padovani EM; Pistolesi C; Fanos V; Messori A; Martini N
    Dev Pharmacol Ther; 1993; 20(3-4):167-73. PubMed ID: 7828449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
    Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O
    Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.